The CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream every weekday at 10:20 a.m. ET, where key moments of the day are discussed. On Thursday, U.S. stocks advanced as Wall Street analyzed fresh labor market data and corporate earnings. Weekly jobless claims hit their highest level since August, raising expectations for interest rate cuts by the Federal Reserve. The Dow Jones Industrial Average gained 180 points, or nearly 0.5%, continuing its streak of seven consecutive positive days. Jim Cramer noted the relatively quiet week for economic news and Fed pronouncements.
Abbott Laboratories’ stock was slightly lower on Thursday, but the CNBC Investing Club remained positive about the medical technology company. Despite ongoing baby formula lawsuits, Abbott’s formula has been praised by medical professionals as life-saving nutrition. A strong quarterly earnings report in April also contributed to the club’s optimism. The club also bought more shares of GE Healthcare on Wednesday, as the stock continues to recover from its earnings plunge in April. Despite a weaker-than-expected quarter, management has maintained their full-year guidance, and Jim Cramer believes that demand for GE Healthcare’s products will continue to rise as the company integrates artificial intelligence into its offerings.
As a subscriber to the CNBC Investing Club with Jim Cramer, members receive trade alerts before Jim makes a trade. There is a waiting period of 45 minutes after the trade alert is issued before buying or selling a stock in the charitable trust’s portfolio, and 72 hours after Jim talks about a stock on CNBC TV. These procedures help ensure transparency and fair trade practices within the club. All information provided by the club is subject to terms and conditions, privacy policy, and disclaimer. There is no fiduciary obligation or duty created by receiving information from the club, and no specific outcome or profit is guaranteed.
Overall, the CNBC Investing Club with Jim Cramer remains optimistic about the market, with a focus on specific stocks such as Abbott Laboratories and GE Healthcare. Despite challenges such as ongoing lawsuits and weaker-than-expected earnings, the club sees potential for growth and profitability in these companies. By following the trade alerts and guidelines set by the club, subscribers can participate in informed investing decisions alongside Jim Cramer. The club emphasizes the importance of thorough research, patience, and adherence to their protocols in order to achieve successful outcomes in the stock market.
